Hanson Jeffrey T 4

What Happened

• Jeffrey T. Hanson, Interim Chief Executive Officer, President and a director of American Healthcare REIT, was granted 42,756 restricted stock units (RSUs) on March 26, 2026. The award is reported as a derivative acquisition at $0.00 on the Form 4 (this is a non‑cash equity grant). Each RSU converts into one share of common stock upon vesting.

Key Details

• Transaction date and price: March 26, 2026 — 42,756 RSUs @ $0.00 (award / derivative).
• Vesting: RSUs vest on the earlier of (1) March 15, 2027 or (2) within 30 days after his termination as Interim CEO. If his Interim CEO service ends before Dec 31, 2026, he receives a pro‑rated portion of the grant‑date value.
• Shares owned after transaction: not specified in the provided Form 4 summary.
• Filing timeliness: Form 4 filed March 30, 2026 covering the March 26 transaction — appears to be filed within the SEC’s Form 4 timing window (not flagged as late).
• Footnotes: F1 confirms 1 RSU = 1 share on conversion; F2 describes the time‑based vesting and pro‑rata treatment.

Context

• This was an equity compensation award, not an open‑market purchase or sale. RSU grants compensate executives and align incentives; they do not represent immediate shareholder sales or purchases and will only become tradable shares if and when they vest and convert. The pro‑rata vesting language ties part of the award to his tenure as Interim CEO.